Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea
This study has been completed.
Study NCT00621218   Information provided by Coria Laboratories, Ltd.
First Received: February 12, 2008   Last Updated: December 17, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rosacea
More general conditions related to this trial
Skin Diseases
Interventions listed in this trial
tretinoin gel 0.05%
vehicle
Additional drug interventions recognized in this trial
Tretinoin
More general drug interventions related to this trial
Antineoplastic Agents
Dermatologic Agents
Keratolytic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Coria Laboratories, Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services